News

Vironova's COO, Maria Homman was recently involved in staging a seminar and debate at IVA (The Royal Swedish Academy of Engineering Sciences) as part of the IFG Leadership Development program. The subject translates to "AI the new leader in a...

Successful presence at cell and gene therapy meet Last week Vironova attended the 26th annual meeting of the European Society of Gene and Cell Therapy  (ESGCT)  in Lausanne, Switzerland.

A conference paper was presented by Vironova’s collaborator Elisabeth Wetzer at the Workshop on BioImage Computing, European Conference on Computer Vision (ECCV), 8-14 September in Munich.

Helping to sharpen Sweden’s edge in advanced technology development Maria Homman, COO of Vironova has been out travelling with the IFG leadership development program of IVA (the royal Swedish Academy of Engineering Sciences). The program is based on...

A successful meeting at VLPNPV 2018 in Bern, Switzerland Last week, 25-27 September, Vironova attended the Virus-Like Particle & Nano-Particle Vaccines conference in Bern, Switzerland.  We succeeded in generating even more awareness of the Vironova...

Joint seminar between Vironova Biosafety and AsahiKASEI on virus safety and filtration  

This week Vironova is participating in a panel discussion at the Cell and Gene Therapy Bioprocessing and Commercialization conference in Boston, represented by Nina Forsberg, Marketing Director.

Vironova scientists continue to influence the field - new standard approved In the spring of 2017 Vironova, being identified as leading experts in the characterization of liposomes, was invited by the FDA to participate in developing a standard for...

Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency

The Vironova team of Josefina Nilsson, Head EM services and Martin Ryner, Manager Strategic Development presented a webinar on the 11th April with over 200 people participating.